Skip to content
★ Sign in to follow
王

王曌

Board Director
Director
爱博医疗
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€46k
▼ Sales (0 ops.)
—

Latest filing published 27 Aug 2024 for 爱博医疗, €28k.

Filing timeline

BuySale
王曌

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
100%
Median T+90
+17.4%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 27 Aug 2024 · 803 days ago · €28k
    +9.7%
    Entry CN¥73.06 · Close at T+365 CN¥80.18
  • Filed 26 Aug 2024 · 804 days ago · €19k
    +3.5%
    Entry CN¥73.50 · Close at T+365 CN¥76.05

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

王曌: trading record in brief

All filings by 王曌 on record concern 爱博医疗, in the capacity of board member. Over a trading history stretching from 26 August 2024 to 27 August 2024, the count stands at 2 filings.

On the market, this insider has only ever bought: 2 purchases, €46k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 27 August 2024 came the latest disclosure, an open-market purchase for €28k in 爱博医疗. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Companies and markets linked to 王曌

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    董事,高级管理人员,核心技术人员Executives爱博医疗
    221,343 CNY25SSE
    3,053 shares60.0% of flowA股XSHGSSE:173000008014222430
    Canonical exit: 25 Nov 2024 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives爱博医疗
    147,500 CNY23SSE
    2,000 shares40.0% of flowA股XSHGSSE:173000008014222400
    Canonical exit: 24 Nov 2024 (T+90)

2 of 2 declarations